Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depo-Trigger trial: GnRH agonist depot trigger for final oocyte maturation
2020-005208-20Phase 2Completed
- Sponsor
- UZ Brussel
- Start
- Jun 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of triptorelin in breast cancer, sponsored by UZ Brussel. Primary endpoint: Hormone levels after ovulation trigger. Started Jun 2021; status: completed.
02
Drugs
triptorelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2020-005208-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005208-20.